Renjie Chai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Renjie Chai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Dunliang Ma
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
1 shared publication - Feihuang Han
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
1 shared publication - Feng Wang
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
1 shared publication - Qiheng Wan
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
1 shared publication - Shupei Wu
Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, 510260, China
1 shared publication - Song Wen
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 581
Guidezilla Guide Extension Catheter Use During Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Success and Long-Term Outcomes
Background: The role of the Guidezilla guide extension catheter during retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains uncertain. We examined its associations with procedural success, reported complications, and subsequent clinical events. Methods: This retrospective single-centre study included 819 patients undergoing elective retrograde CTO PCI between January 2011 and April 2023. Procedural associations were evaluated using logistic regression and propensity score matching. Long-term outcomes were evaluated using Kaplan–Meier analysis and Cox regression. Results: The Guidezilla guide extension catheter was used in 281 patients (34.3%). Retrograde technical success was 95.0% versus 87.0%, and final recanalisation success was 96.1% versus 88.3% (both p < 0.001). Corresponding adjusted odds ratios (ORs) were 3.80 (95% confidence interval [CI] 2.11–7.32) and 4.30 (95% CI 2.26–8.94; both p < 0.001). Associations persisted in 259 matched pairs (ORs 2.54, 95% CI 1.34–4.82, and 2.90, 95% CI 1.41–5.95; both p = 0.004). Reported in-hospital complications did not differ significantly, but rare events limited comparative safety assessment. In the fully adjusted Cox model, hazard ratios (HRs) were 0.99 (95% CI 0.48–2.04; p = 0.976) for cardiovascular events and 1.28 (95% CI 0.81–2.03; p = 0.295) for major adverse cardiovascular events. Conclusions: Guidezilla guide extension catheter use was associated with higher procedural success. These observational findings remain susceptible to selection bias and residual confounding, while limited event numbers preclude firm conclusions regarding comparative safety and long-term outcomes. Prospective confirmation is warranted.
- 10 November 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (11) , 581
Open AccessGuidezilla Guide Extension Catheter Use During Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention: Procedural Success and Long-Term Outcomes
Background: The role of the Guidezilla guide extension catheter during retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains uncertain. We examined its associations with procedural success, reported complications, and subsequent clinical events. Methods: This retrospective single-centre study included 819 patients undergoing elective retrograde CTO PCI between January 2011 and April 2023. Procedural associations were evaluated using logistic regression and propensity score matching. Long-term outcomes were evaluated using Kaplan–Meier analysis and Cox regression. Results: The Guidezilla guide extension catheter was used in 281 patients (34.3%). Retrograde technical success was 95.0% versus 87.0%, and final recanalisation success was 96.1% versus 88.3% (both p < 0.001). Corresponding adjusted odds ratios (ORs) were 3.80 (95% confidence interval [CI] 2.11–7.32) and 4.30 (95% CI 2.26–8.94; both p < 0.001). Associations persisted in 259 matched pairs (ORs 2.54, 95% CI 1.34–4.82, and 2.90, 95% CI 1.41–5.95; both p = 0.004). Reported in-hospital complications did not differ significantly, but rare events limited comparative safety assessment. In the fully adjusted Cox model, hazard ratios (HRs) were 0.99 (95% CI 0.48–2.04; p = 0.976) for cardiovascular events and 1.28 (95% CI 0.81–2.03; p = 0.295) for major adverse cardiovascular events. Conclusions: Guidezilla guide extension catheter use was associated with higher procedural success. These observational findings remain susceptible to selection bias and residual confounding, while limited event numbers preclude firm conclusions regarding comparative safety and long-term outcomes. Prospective confirmation is warranted.